tirzepatide vs semaglutide vs. semaglutide: Study compares cost and health outcomes in obesity Tirzepatide vs Semaglutide: Which Weight

n=338) demonstrated dose-dependent weight loss over 48 weeks: The 24.2% weight loss at the 12 mg dose was the largest mean weight loss reported for any anti-obesity medication at the time of publication

This improved exercise experience increases the likelihood that individuals will maintain regular activity levels long-term

Stomach Pain : Mild abdominal discomfort or bloating can happen as a side effect

However, it is important to note that mean ALT and aspartate aminotransferase (AST) levels remained stable or even decreased by the end of the 48-week treatment period

Wegovy is the brand name for semaglutide, made by Novo Nordisk